18F-FDG PET/CT of transitional cell carcinoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19933624.
- Also identified by DOI 10.2214/AJR.08.1945.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The objective of this article is to provide a practical illustrated review of PET/CT in the imaging evaluation of transitional cell carcinoma. Local evaluation of the primary tumor in patients with transitional cell carcinoma on PET is often limited by the obscuring effect of excreted FDG, but assessment of metabolic activity may still be possible through close correlation with CT images. PET/CT may also be helpful in the detection of disease outside the bladder at nodal or more distant sites and in the assessment of recurrent disease.
Medical subject headings
- Carcinoma, Transitional Cell
- Fluorodeoxyglucose F18
- Positron-Emission Tomography
- Radiopharmaceuticals
- Tomography, X-Ray Computed
- Urinary Bladder Neoplasms